Xencor, Inc.
NASDAQ:XNCRBiotechnology
-$0.13 today
- Market cap
- $2.58B
- Beta
- 0.93
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$2.29
Volume 0.87M
Average 0.80M
XNCR Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Xencor, Inc.NASDAQ: XNCR
Gross Profit · Q2 FY2026 · quarter ended Jun 2026
Gross profit growth accelerates
Q2 FY2026 gross profit of $51.22M rose 25.1% year over year, ahead of the -54.8% change in trailing-twelve-month gross profit. Sequentially, it rose 2528.1% from the prior quarter.
Context
- Gross profit amounted to 91.6% of revenue in FY2025, down 14.4 pp from a year earlier.
- Gross profit increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +25.1% holds above the trailing-twelve-month pace of -54.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 115.06M USD
- Year-over-year change
- +198.2%
- 4-year CAGR
- +8.6%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 115.06M | +198.2% |
| FY2024 | 2024-12-31 | (117.19M) | -167.1% |
| FY2023 | 2023-12-31 | 174.62M | +599.1% |
| FY2022 | 2022-12-31 | (34.98M) | -142.4% |
| FY2021 | 2021-12-31 | 82.6M | — |
Gross Profit vs competitors
How XNCR compares with its peers on the latest reported figures
- Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -54.8% is the 8th highest of 9, against a peer median of +15.8%.
- Gross profit amounts to 43.3% of revenue for XNCR, versus a peer median of 95.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.84B USD | — | -38.3% | 93.0% | |
| LTM Aug 2026 | $607.18M USD | +545.5% | — | 86.5% | |
| LTM Mar 2026 | $381.15M USD | +15.4% | +28.0% | 98.8% | |
| LTM Mar 2026 | $109.85M USD | +16.2% | -9.3% | 69.9% | |
| LTM Mar 2026 | $63.98M USD | +230.5% | +113.5% | 88.1% | |
| LTM Jun 2026 | $54.24M USD | -13.2% | -7.8% | 99.4% | |
| LTM Jun 2026 | $45.46M USD | -54.8% | — | 43.3% | |
| FY2025 | €2.79M EUR | -77.9% | -22.6% | 100.0% | |
| LTM Jun 2024 | -$118.77K USD | — | -6.2% | 14.6% | |
| LTM Sep 2026 | -$742K USD | +99.6% | — | 662.5% | |
| FY2025 | -A$56.37M AUD | -49.5% | — | 1117.6% | |
| Peer median (excluding XNCR) | — | +15.8% | -7.8% | 95.9% | |
Competitors are the stored peer set for XNCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 275.11M | 164.58M | 174.62M | 110.49M | 125.58M |
| Cost of Revenue | 192.51M | 199.56M | 0 | 227.69M | 10.51M |
| Gross Profit | 82.6M | (34.98M) | 174.62M | (117.19M) | 115.06M |
| Gross Margin | 30.0% | -21.3% | 100.0% | -106.1% | 91.6% |
| Research & Development | 192.51M | 199.56M | 253.6M | 227.69M | 239.43M |
| Selling, General & Admin | 38.84M | 47.49M | 53.38M | 58.89M | 63.64M |
| Operating Expenses | 38.84M | 47.49M | 306.98M | 61.22M | 292.57M |
| Depreciation & Amortization | 7.49M | 8.8M | 11.5M | 12.11M | 10.51M |
| EBITDA | 90.14M | (45.7M) | (101.96M) | (186.17M) | (46.98M) |
| EBITDA Margin | 32.8% | -27.8% | -58.4% | -168.5% | -37.4% |
| Operating Income | 43.77M | (82.47M) | (132.36M) | (178.41M) | (177.5M) |
| Operating Margin | 15.9% | -50.1% | -75.8% | -161.5% | -141.4% |
| Interest Income | 862K | 4.82M | 18.63M | 31.93M | 27.52M |
| Interest Expense | 13K | 0 | 0 | 36.64M | 31.93M |
| Other Income / Expenses | 38.86M | 27.97M | 12.73M | (56.52M) | 87.87M |
| Income Before Tax | 82.63M | (54.51M) | (119.63M) | (234.92M) | (89.42M) |
| Pre-Tax Margin | 30.0% | -33.1% | -68.5% | -212.6% | -71.2% |
| Income Tax Expense | 0 | 673K | 13.66M | 1.62M | 2.5M |
| Net Income | 82.63M | (55.18M) | (133.13M) | (232.62M) | (91.92M) |
| Net Margin | 30.0% | -33.5% | -76.2% | -210.5% | -73.2% |
| EPS (Basic) | 1.42 | (0.93) | (2.08) | (3.58) | (1.24) |
| EPS (Diluted) | 1.37 | (0.93) | (2.08) | (3.58) | (1.24) |
| Weighted Avg Shares | 58.38M | 59.65M | 60.5M | 65.04M | 74.24M |
| Weighted Avg Shares (Diluted) | 60.5M | 59.65M | 60.5M | 65.04M | 74.24M |
Xencor, Inc.
NASDAQ:XNCR
Intrinsic Alpha fair value
Locked
Current Price
$34.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.